DT&CRO CO., Ltd. (383930.KQ)
KOSDAQ · KRW · Healthcare · Biotechnology
₩2,030 (-3.10%) as of
Key statistics
- Market cap
- 25.95B
- Dividend yield
- 0.00%
- 52-week range
- 1,430.00 – 4,115.00
- Beta
- 1.13
- Revenue (TTM)
- 49B
- Profit margin
- -34.88%
- Volume
- 45.31k
About DT&CRO CO., Ltd.
DT&CRO CO., Ltd. operates as a full-service CRO provider in South Korea. The company conducts a series of consigned studies ranging from non-clinical GLP toxicity, PK, and efficacy tests required for licensing of pharmaceuticals, chemicals, health functional food, cosmetics, and medical devices to analysis, bioactivity, clinical trials, and licensing consulting. DT&CRO CO., Ltd. was founded in 2017 and is based in Yongin-si, South Korea.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Yongin-si, South Korea
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.